Association between completed suicide and bipolar disorder: A systematic review of the literature

Journal of Affective Disorders

Volumn 242, Issue , 2019, Pages 111-122

  Plans, L ^a   Barrot, C ^b   Nieto, E ^a   Rios, J ^c,d   Schulze, T G ^e   Papiol, S ^e   Mitjans, M ^f   Vieta, E ^b   Benabarre, A ^b  

^a Althaia   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; NEUROTRANSMITTER;

AGITATED DEPRESSION; ANXIETY DISORDER; BIPOLAR DISORDER; CLINICAL FEATURE; COMPLETED SUICIDE; DISEASE ASSOCIATION; ELECTROCONVULSIVE THERAPY; HEREDITY; HUMAN; MAJOR AFFECTIVE DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL TREATMENT; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; ADULT; COMORBIDITY; CONSENSUS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; VIOLENCE; WORLD HEALTH ORGANIZATION;

ADULT; BIPOLAR DISORDER; COMORBIDITY; CONSENSUS; HUMANS; LITHIUM; RISK FACTORS; SUICIDE; VIOLENCE; WORLD HEALTH ORGANIZATION;

EID: 85052505521     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2018.08.054     Document Type: Review

References (232)

1. Akiskal, H, Benazzi, F, Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states?. Psychopathology 38 (2005), 273–280.
2. Althoff, R, Hudziak, J, Willemsen, G, Hudziak, V, Bartels, M, Boomsma, D, Genetic and environmental contributions to self-reported thoughts of self-harm and suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B (2012), 120–127.
3. Alvarez, M, Roura, P, Oses, A, et al. Prevalence and clinical impact of childhood trauma in patients with severe mental disorders. J. Nerv. Ment. Disord. 199 (2011), 156–161.
4. Angst, F, Stassen, H, Clayton, P, Angst, J, Mortatility of patients with mood disorders: follow-up over 34–38 years. J. Affect. Disord. 68 (2002), 167–181.
5. Angst, J, Angst, F, Gerber-Werder, R, Gamma, A, Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years’ follow-up. Arch. Suicide Res. 9 (2005), 279–300.
6. Anguelova, M, Benkelfat, C, Turecki, G, A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol. Psychiatry 8 (2003), 646–653.
7. Antypa, N, Antonioli, M, Serretti, A, Clinical, psychological and environmental predictors of prospective suicide events in patients with bipolar disorder. J. Psychiatry 47 (2013), 1800–1808.
8. Antypa, N, Serreti, A, Rujescu, D, Serotonergic genes and suicide: a systematic review. Eur. Neropsychopharmacol. 23 (2013), 1125–1142.
9. Antypa, N, Souery, D, Tomasini, M, et al. Clinical and genetic factors associated with suicide in mood disorder patients. Eur. Arch. Psychiatry Clin. Neurosci. 266 (2016), 181–193.
10. Appleby, L, Shaw, J, Amos, T, et al. Suicide within 12 months of contact with mental health services: national clinical survery. BMJ 318 (1999), 1235–1239.
11. Arsenualt-Lapierre, G, Kim, C, Turecki, G, Psychiatric diagnoses in 3257 suicides: a meta-analysis. BMC Psychiatry, 4, 2004, 37.
12. Asberg, M, Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann. N. Y. Acad. Sci. 836 (1997), 158–181.
13. Axelsson, R, Lagerkvist-Briggs, M, Factors predicting suicide in psychotic patients. Eur. Arch. Psychiatry Clin. Neurosci. 241 (1992), 259–266.
14. Azorin, J, Kaladjian, A, Adida, M, et al. Risk factors associated with lifetime suicide attempts in bipolar I patients: findings from a French national cohort. Compr. Psychiatry 50 (2009), 115–120.
15. Baillargeon, J, Penn, J, Thomas, C, et al. Psychiatric disorders and suicide in the nation's largest state prision system. J. Am. Acad. Psychiatry Law 37 (2009), 188–193.
16. Baldessarini, R, Tondo, L, Davis, P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 8 (2006), 625–639.
17. Baldessarini, R, Tondo, L, Hennen, J, Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J. Clin. Psychiatry 60:Suppl 2 (1999), 77–84.
18. Baldessarini, R, Tondo, L, Hennen, J, Lithium treatment and suicide risk in major affective disorders: update and new findings. J. Clin. Psychiatry 64:5 (2003), 44–52.
19. Banerjee, R, Ghosh, A, Ghosh, B, Bhattacharyva, S, Mondal, A, Decreased mRNA and protein expression of BDNF, NGF and their receptors in the hippocampus from suicide: an analysis in human postmortem brain. Clin. Med. Insights Pathol. 6 (2013), 1–11.
20. Barner-Rasmussen, P, Suicide in psychiatric patients in Denmark, 1971 – 1981. II. Hospital utilization and risk groups. Acta Psychiatr. Scand. 73 (1986), 449–455.
21. Bellivier, F, Chaste, P, Malafosse, A, Association between the TPH gene A218C polymorphism and suicidal behaviour: a metanalysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 124B (2004), 87–91.
22. Ben - Efraim, Y, Wasserman, D, Wasserman, J, Sokolowski, M, Family-based study of HTR2A in suicide attempts: observed gene, gene x environment and parent-of-origin associations. Mol. Psychiatry 18:7 (2013), 758–766.
23. Benazzi, F, Koukopoulos, A, Akiskal, H, Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur. Psychiatry 19 (2004), 85–90.
24. Bloch, Y, Levcovith, Y, Bloch, A, Mendlovic, S, Ratzoni, G, Electroconvulsive therapy in adolescents: similarities to and differences from adults. J. Am. Acad. Child Adolesc. Psychiatry 40 (2001), 1332–1336.
25. Born, C, Dittman, S, Post, R, Grunze, H, Newer prophylactic agents for bipolar disorder and their influence on suicidality. Arch. Suicide Res. 9 (2005), 301–306.
26. Bortolato, M, Pivac, N, Muck Seler, D, et al. The role of the serotonergic system at the interface of aggression and suicide. Neuroscience 236 (2013), 160–185.
27. Bowden, C, Fawcett, J, Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder. JAMA, 291(8), 2004, 939.
28. Brent, D, Bridge, J, Johnson, B, Connolly, J, Suicidal behavior runs in families. A controlled family study of adolescents suicide victims. Arch. Gen. Psychiatry 53 (1996), 1145–1152.
29. Brezo, J, Bureau, A, Mérette, C, et al. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Mol. Psychiatry 15 (2010), 831–843.
30. Brezo, J, Klempan, T, Turecki, G, The genetics of suicide: a critical review of molecular studies. Psychiatr. Clin. North Am. 31 (2008), 179–203.
31. Burgess, S, Geddes, J, Hawton, K, et al. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst. Rev., 2(CD003013), 2001.
32. Buttenschon, H, Flint, T, Foldager, L, Qin, P, Chrisoffersen, S, Hassen, N, et al. An association study of suicide and candidate genes in the serotonergic system. J. Affect. Disord. 148 (2013), 291–298.
33. Calati, R, Porcelli, S, Giegling, I, Hartmann, A, Möller, H, De Ronchi, D, et al. Catechol-O-methyltransferase gene modulation on suicidal behavior and personality traits: review,meta-analysis and association study. J. Psychiatry Res. 45 (2011), 309–321.
34. Carballo, J, Harkavy-Friedman, J, Burke, A, Sher, L, Baca-Garcia, E, Sullivan, G, et al. Family history of suicidal behaviour and early traumatic experiences: additive effect on suicidality and course of bipolar illness?. J. Affect. Disord. 109 (2008), 57–63.
35. Cataldo, A, McPhie, D, Lange, N, et al. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am. J. Pathol. 177 (2010), 575–585.
36. Cavanagh, J, Carson, A, Sharpe, M, et al. Psychological autopsy studies of suicide: a systematic review. Psychol. Med. 33:3 (2003), 395–405.
37. Cipriani, A, Hawton, K, Stockton, S, Geddes, J, Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ, 346, 2013, f3646.
38. Clayden, R, Zaruk, A, Meyre, D, Thabane, L, Samaan, Z, The association of attempted suicide with genetic variants in the SCL6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analyses. Transl. Psychiatry, 2, 2012.
39. Clements, C, Morris, R, Jones, S, et al. Suicide in bipolar disorder in a national English sample, 1996-2009: frequency, trends and characteristics. Psychol. Med. 43:12 (2013), 2593–2602.
40. Clements, C, Morriss, R, Jones, S, et al. Suicide in bipolar disorder in a national English sample, 1996-2009: frequency, trends and characteristics. Psychol. Med. 107 (2013), 1–10.
41. Collins, J, McFarland, B, Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J. Affect. Disord. 107 (2008), 23–38.
42. Courtet, P, Jollant, F, Castelnau, D, Astruc, B, Buresi, C, Malafosse, A, Implication of genes of the serotonergic system on vulnerability to suicidal behavior. J. Psychiatry Neurosci. 29 (2004), 350–359.
43. Courtet, P, Jollant, F, Castelnau, D, Buresi, C, Malafosse, A, Suicidal behaviour: relationship between phenotype and serotoninergic genotype. Am. J. Med. Genet. C Semin. Med. Genet. 133C (2005), 25–33.
44. Coventry, W, James, M, Eaves, L, Gordon, S, Gillespie, N, Ryan, L, et al. Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (2010), 757–765.
45. Currier, D, Mann, J, Stress, genes and the biology of suicidal behavior. Psychiatr. Clin. North Am. 31 (2008), 247–269.
46. Dalton, E, Cate-Carter, T, Mundo, E, et al. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord. 5:1 (2003), 58–61.
47. De Paermentier, F, Mauger, J, Lowther, S, Crompton, M, Katona, C, Horton, R, Brain alpha-adrenoreceptors in depressed suicides. Brain Res. 757 (1997), 60–68.
48. Dennehy, E, Marangell, L, Allen, M, et al. Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorders (STEP-BD). J. Affect. Disord. 133 (2011), 423–427.
49. Desai, R, Dausey, D, Rosenheck, R, Mental health service delivery and suicide risk: the role of individual patient and facility factors. Am. J. Psychiatry 162 (2005), 311–318.
50. Dunne, E, Family psychoeducation with suicide attempters. Suicidology and Suicide Prevention: A Global Perspective, 2009, 439–443.
51. Dunner, D, Gershon, E, Goodwin, F, Heritable factors in the severity of affective illness. Biol. Psychiatry 11 (1976), 31–42.
52. Dutta, R, Boydell, J, Kennedy, N, Van, OJ, Fearon, P, Murray, R, Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychol. Med. 37 (2007), 839–847.
53. Dwivedi, Y, Brain-derived neurotrophic factor and suicide pathogenesis. Ann. Med. 42 (2010), 87–96.
54. Dwivedi, Y, Rao, J, Rizavi, H, et al. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in post-mortem brain of suicide subjects. Arch. Gen. Psychiatry 60 (2003), 273–282.
55. Dwivedi, Y, Rizavi, H, Conley, R, et al. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in post-mortem brain of suicide subjects. Arch. Gen. Psychiatry 60 (2003), 804–815.
56. Dwivedi, Y, Rizavi, H, Zhang, H, et al. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK Kinase 1 (MEK1). Int. J. Neuropsychopharmacol. 12 (2009), 1337–1354.
57. Ekinci, O, Albayrak, Y, Ekinci, A, Caykoylu, A, Relationship of trait impulsivity with clinical presentation in euthymic bipolar disorder patients. Psychiatry Res. 190 (2011), 259–264.
58. Escriba, P, Ozaita, A, Garcia-Sevilla, J, Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 29 (2004), 1512–1521.
59. Fattal, O, Budur, K, Vaughan, A, Franco, K, Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 47 (2006), 1–7.
60. Fiori, L, Wanner, B, Jomphe, V, Croteau, J, Vitaro, F, Tremblay, R, et al. Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide. PLoS One, 5, 2010.
61. Fudalej, S, Ilgen, M, Fudalej, M, Korstrzewa, G, Barry, K, Wojnar, M, et al. Association between tryptophan hydroxylase 2 gene polymorphism and completed suicide. Suicide Life Threat. Behav. 40 (2010), 553–560.
62. Fukutake, M, Hishimoto, A, Nishiguchi, N, Nushinda, H, Ueno, Y, Shirakawa, O, et al. Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females. Prog. Neuropsychoparmacol. Biol. Psychiatry 32 (2008), 428–433.
63. Galfalvy, H, Huang, Y, Oquendo, M, Currier, D, Mann, J, Increased risk of suicide attempt in mood disorders and TPH1 genotype. J. Affect. Disord. 115 (2009), 331–338.
64. Galfalvy, H, Oquendo, M, Carballo, J, et al. Clinical predictors of suicidal acts after major depression in bipolar disorder: a prospective study. Bipolar Disord. 8 (2006), 586–595.
65. Garno, J, Goldberg, J, Ramirez, P, Ritzler, B, Bipolar disorder with comorbid cluster B personality disorder features: impact on suicidality. J. Clin. Psychiatry 66 (2005), 339–345.
66. Gelenberg, A, Can lithium help to prevent suicide?. Acta Psychiatr. Scand. 104 (2001), 161–162.
67. Ghaemi, S, Rosenquist, K, Ko, J, et al. Antidepressant treatment in bipolar versus unipolar depression. Am. J. Psychiatry 161 (2004), 163–165.
68. Gibbons, R, Brown, C, Hur, K, Marcus, S, Bhaumik, D, Mann, J, Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am. J. Psychiatry 164 (2007), 1044–1049.
69. Gomez, E, Forti, M, Guiterrez, B, Belmonte, A, Martin, C, Trastornos psiquiátricos en los casos de suicidio consumado en un área hospitalaria entre 2007–2010. Rev. Psiquiatr. Salud Ment. 9:1 (2016), 31–38.
70. Gonzalez-Pinto, A, Barbeito, S, Alonso, M, et al. Poor long-term prognosis in mixed bipolar patients: 10-year outcomes in the Vitoria prospective naturalistic study in Spain. J. Clin. Psychiatry 72 (2011), 671–676.
71. Gonzalez-Pinto, A, Mosquera, F, Alonso, M, et al. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord. 8 (2006), 618–624.
72. Goodwin, F, Fireman, B, Simon, G, et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290:11 (2003), 1467–1473.
73. Goodwin, F, Fireman, B, Simon, G, Hunkeler, E, Lee, J, Reviki, D, Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 209 (2003), 1467–1473.
74. Goodwin, F, Jamison, K, Maniac-Depressive Illness. 2nd ed., 2007, Oxford University Press, New York editor.
75. Gould, M, Wallenstein, S, Davidson, L, Suicide clusters: a critical review. Suicide Life Threat. Behav. 19 (1989), 17–29.
76. Green, E, Raybould, R, Macgregor, S, Hyde, S, Young, A, O'Donovan, M, et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br. J. Psychiatry 188 (2006), 21–25.
77. Guthrie, E, Kapur, N, Mackway-Jones, K, et al. Randomised controlled trial of brief psychological intervention after deliberate self-poisoning. BMJ 323 (2001), 135–138.
78. Guze, S, Robins, E, Suicide and primary affective disorders. Br. J. Psychiatry 117 (1970), 437–438.
79. Guzzeta, F, Tondo, L, Centorrino, F, Baldessarini, R, Lithium treatment reduces suicide risk in recurrent major depressive disorder. J. Clin. Psychiatry 68 (2007), 380–383.
80. Harris, E, Barraclough, B, Suicide as an outcome for mental disorders. A meta-analysis. Br. J. Psychiatry 170 (1997), 205–228.
81. Harris, E, Barraclough, B, Excess mortality of mental disorder. Br. J. Psychiatry 173 (1998), 11–53.
82. Hawton, K, Arensman, E, Townsend, E, et al. Deliberate self-harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. BMJ 317 (1998), 441–447.
83. Hawton, K, Sutton, L, Haw, C, et al. Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors. J. Clin. Psychiatry 66:6 (2005), 693–705.
84. Henry, C, Van den Bulke, D, Bellivier, F, et al. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J. Clin. Psychiatry 64 (2003), 331–335.
85. Hepp, U, Wittmann, L, Schnyder, U, Michel, K, Psychological and psychosocial interventions after attempted suicide: an overview of treatment studies. Crisis 25 (2004), 108–117.
86. Höfer, P, Schosser, A, Calati, R, Serretti, A, Massat, I, Kocabas, N, et al. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on attempt and suicide risk in depressed patients with insufficient response to treatment - a European Multicentre Study. Int. Clin. Psychopharmacol. 31 (2016), 1–7.
87. Hong, C, Huo, S, Yen, F, Tung, C, Pan, G, Tsai, S, Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48 (2003), 186–189.
88. Hoyer, E, Mortensen, P, Olesen, A, Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br. J. Psychiatry 176 (2000), 76–82.
89. Hoyer, E, Olesen, A, Mortensen, P, Suicide risk in patients hospitalised because of an affective disorder: a follow-up study, 1973–1993. J. Affect. Disord. 78 (2004), 209–217.
90. Huber, R, Coon, H, Kim, N, Renshaw, P, Kondo, D, Altitude is a risk factor for completed suicide in bipolar disorder. Med. Hypotheses 82:3 (2014), 377–381.
91. Ilgen, M, Bohnert, A, Ignacio, R, et al. Psychiatric diagnoses and risk of suicide in veterans. Arch. Gen. Psychiatry 67 (2010), 1152–1158.
92. Inskip, H, Harris, E, Barraclough, B, Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br. J. Psychiatry 172 (1998), 35–37.
93. Isometsa, E, Suicidal behaviour in mood disorders – who, when, and why?. Can. J. Psychiatry 59:3 (2014), 120–130.
94. Isometsa, E, Heikkinen, M, Henriksson, M, et al. Recent life events and completed suicide in bipolar affective disorder. A comparison with major depressive suicides. J. Affect. Disord. 33 (1995), 99–106.
95. Isometsa, E, Henriksson, M, Aro, H, Lönqvist, J, Suicide in bipolar disorder in Finland. Am. J. Psychiatry 151 (1994), 1020–1024.
96. Jacobs, D, Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am. J. Psychiatry 160:11 (2003), 1–60.
97. Jamison, K, Suicide and bipolar disorder. J. Clin. Psychiatry 61:9 (2000), 47–51.
98. Jimenez, E, Arias, B, Mitjans, M, Goikolea, J, Roda, E, Ruiz, V, et al. Association between GSK3β gene and increased impulsivity in bipolar disorder. Eur. Neuropsychopharmacol. 24:4 (2014), 510–518.
99. Jimenez, E, Arias, B, Mitjans, M, Goikolea, J, Roda, E, Saiz, P, et al. Genetic variability at IMPA2, INPP1 and GSK3beta increases the risk of suicidal behavior in bipolar patients. Eur. Neuropsychopharmacol. 23:11 (2013), 1452–1462.
100. Joiner, TJ, Brown, J, Wingate, L, The psychology and neurobiology of suicidal behaviour. Annu. Rev. Psychol. 56 (2005), 287–314.
101. Jou, S, Chiu, N, Liu, C, Mitochondrial dysfunction in psychiatric disease. Chan Gung Med. J. 32 (2009), 370–379.
102. Karch, D, Barker, L, Strine, T, Race/ethnicity, substance abuse, and mental illness among suicide victims in 13 US states: 2004 data from the National Violent Death Reporting System. Injury Prev. 12:2 (2006), 22–27.
103. Kato, T, The role of mitochondrial dysfunction in bipolar disorder. Drug News Perspect. 19 (2006), 597–602.
104. Kato, T., Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 21 (2007), 1–11.
105. Katz, R, Role of serotoninergic mechanisms in animal models of predation. Prog. Neuropsychoparmacol. 4 (1980), 219–231.
106. Ke, L, Qi, Z, Ping, Y, Ren, C, Effect of SNP at position 40237 in exon 7 of the TPH2 gene on susceptibility to suicide. Brain Res. 1122 (2006), 24–26.
107. Kessing, L, Sondergard, L, Kvist, K, Andersen, P, Suicide risk in patients treated with lithium. Arch. Gen. Psychiatry 62 (2005), 860–866.
108. Khalsa, H, Salvatore, P, Hennen, J, Baethge, C, Tohen, M, Baldessarini, R, Suicidal events and accidents in 216 first – episode bipolar I disorder patients: predictive factors. J. Affect. Disord. 106 (2008), 179–184.
109. Kim, B, Kim, C, Hong, J, Kim, S, Lee, C, Joo, Y, Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the met allele with suicidal behaviour of bipolar patients. Neuropsychobiology 58 (2008), 97–103.
110. Kohli, M, Salyakina, D, Pfenning, A, Lucae, S, Horstmann, S, Menke, A, et al. Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. Arch. Gen. Psychiatry 67 (2010), 348–359.
111. Konradi, C, Eaton, M, MacDonald, M, et al. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61 (2004), 300–308.
112. Kovacsics, C, Gottesman, I, Gould, T, Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu. Rev. Pharmacol. Toxciol. 49 (2009), 175–198.
113. Lemonde, S, Turecki, G, Bakish, D, Du, L, Hrdina, P, Bown, C, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23:25 (2003), 8788–8789.
114. Leverich, G, McElroy, S, Suppes, T, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol. Psychiatry 51 (2002), 288–297.
115. Levi, F, La Vecchia, C, Lucchini, F, et al. Trends in mortality from suicide, 1965-99. Acta Psychiatr. Scand. 108 (2003), 341–349.
116. Li, D, He, L, Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotyping meta-analyses. Hum. Genet. 119 (2006), 233–240.
117. Li, D, He, L, Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behaviour. Mol. Psychiatry 12 (2007), 47–54.
118. Liberati, A, Altman, DG, Tetzlaff, J, Mulrow, C, Gotzache, PC, Ionnaidis, JP, et al. The PRISMA Statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med., 6(7), 2009.
119. Licht, R, Vestergaard, P, Brodersen, A, Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up. Bipolar Disord. 10 (2008), 79–86.
120. Lin, C, Bai, Y, Hu, P, et al. Substance use disorders among inpatients with bipolar disorder and major depressive disorder in a general hospital. Gen. Hosp. Psychiatry 20 (1998), 98–101.
121. Lin, P, Tsai, G, Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol. Psychiatry 55 (2004), 1023–1030.
122. Linehan, M, Comtois, K, Murray, A, et al. Two-year randomized controlled trial and follow-up of dialectal behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch. Gen. Psychiatry, 63, 2006, 757.
123. Liu, L, Foroud, R, Xuei, X, Berrettini, W, Byerley, W, Coryell, W, et al. Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder. Psychiatr. Genet. 18 (2008), 267–274.
124. Lohoff, F, Sander, T, Ferraro, T, Dahl, J, Gallinat, J, Berrettini, W, Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 139B (2005), 51–53.
125. Lonnqvist, J, Major psychiatric disorders in suicide and suicide attempters. Wasserman, D., Wasserman, C., (eds.) Suicidology and Suicide prevention: a Global Perspective, 2009, Oxford University Press, Oxford, 275–286.
126. Lopez, P, Mosquera, F, De Leon, K, et al. Suicide attempts in bipolar patients. J. Clin. Psychiatry 62 (2001), 963–966.
127. Lopez, V, Detera - Wadleigh, S, Cardona, I, Kassem, L, McMahon, F, National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium. Nested association between genetic variation in tryptophan hydroxylase II, Bipolar affective disorder, and suicide attempts. Biol. Psychiatry 61 (2007), 181–186.
128. Mackinnon, D, Potash, J, McMahon, F, et al. Rapid mood switching and suicidality in familial bipolar disorder. Bipolar Disord. 7 (2005), 441–448.
129. MacQueen, G, Young, L, Bipolar II disorder: symptoms, course, and response to treatment. Psychiatr. Serv. 52 (2001), 358–361.
130. Magno, L, Miranda, D, Neves, F, Pimenta, G, Mello, M, De Marco, L, et al. No Association between AKT1 but not AKT1P genetic variants and increased risk for suicidal behavior in bipolar patients. Genes Brain Behav. 9 (2010), 411–418.
131. Mann, J, A current perspective of suicide and attempted suicide. Ann. Internal Med. 136 (2002), 302–311.
132. Mann, J, Neurobiology of suicidal behaviour. Nat. Rev. Neurosci. 4 (2003), 819–828.
133. Mann, J, The serotonergic system in mood disorders and suicidal behaviour. Philos. Trans. R. Soc. L B Biol. Sci., 368, 2013.
134. Mann, J, Brent, D, Arango, V, The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24 (2001), 467–477.
135. Marangell, L, Bauer, M, Dennehy, E, et al. Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord. 8 (2006), 566–575.
136. Marangell, L, Dennehy, E, Wisniewski, S, et al. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J. Clin. Psychiatry 69 (2008), 916–922.
137. Martin-Guerrero, I, Callado, L, Saitua, K, Rivero, G, Garcia-Orad, A, Meana, J, The N251K functional polymorphism in the alpha(2A)-adrenoceptor gene is not associated with depression: a study in suicide completers. Psychopharmacology (Berl.) 184 (2006), 82–86.
138. Maser, J, Akiskal, H, Schettler, P, et al. Can temperament identify affectively ill patients who engage in lethal or near-lethal suicidal behaviour? A 14-year prospective study. Suicide Life – Threat Behav 32 (2002), 10–32.
139. McGuffin, P, Marusic, A, Farmer, A, What can psychiatric genetics offer suicidology. Crisis 22 (2001), 61–65.
140. McGuffin, P, Perroud, N, Uher, R, et al. The genetics of affective disorder and suicide. Eur. Psychiatry 25 (2010), 275–277.
141. McIntyre, R, Muzina, D, Kemp, D, et al. Bipolar disorder and suicide: research synthesis and clinical translation. Curr. Psychiatry 10 (2008), 66–72.
142. McIntyre, RS, Muzina, DJ, Kemp, DE, Blank, D, Woldeyohannes, HO, Lofchy, J, et al. Bipolar disorder and suicide: research synthesis and clinical translation. Curr. Psychiatry Rep. 10 (2008), 66–72.
143. Meltzer, H, Baldessarini, R, Reducing the risk for suicide in schizophrenia and affective disorders. J. Clin. Psychiatry 64 (2003), 1122–1129.
144. Mirkovic, B, Lauren, C, Podlipski, M, Frebourg, T, Cohen, D, Gerardin, P, A review of the past 10 years, progress, limitations, and future directions. Front Psychiatry(7), 2016, 158.
145. Moller, H., Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006), 329–343.
146. Muller, D, de Luca, V, Sicard, T, King, N, Strauss, J, Kennedy, J, Brain-derived neurotrophic factor (BDNF) gene and rapid-cylcing bipolar disorder: family-based association study. Br. J. Psychiatry 189 (2006), 317–323.
147. Murphy, T, Ryan, M, Foster, T, Kelly, C, McClelland, R, O'Grady, J, et al. Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B & NTRK2 polymorphisms. Behav. Brain Funct., 7, 2011, 22.
148. Musil, R, Zill, P, Seemüller, F, Bondy, B, Meyer, S, Spellman, I, et al. Genetics of emergent suicidality during antidepressive treatment – data from a naturalistic study on a large sample of inpatients with a major depressive episode. Eur. Neuropsychopharmacol. 23 (2013), 663–674.
149. Neves, F, Malloy-Diniz, L, Romano-Silva, M, Aguiar, G, de Matos, L, Correa, H, Is the serotonin transporter polymorphism (5-HTTLPR) a potential marker for suicidal behavior in bipolar disorder patients?. J. Affect. Disord. 125 (2010), 98–102.
150. Ono, H, Shirakawa, O, Nushida, H, Ueno, Y, Maeda, K, Association between cathecol-O-methyltransferase functional polymorphism and male suicide completers. Neuropsychopharmacology 75 (2004), 807–821.
151. Oquendo, M, Bongiovi-Garcia, M, Galfalvy, H, et al. Sex differences in clinical predictors of suicidal acts after major depression: a prospective study. Am. J. Psychiatry 164 (2007), 134–141.
152. Oquendo, M, Currier, D, Liu, S, et al. Increased risk for suicidal behaviour in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J. Clin. Psychiatry 71:7 (2010), 902–909.
153. Oquendo, M, Lizardi, D, Greenwald, S, Weissman, M, Mann, J, Rates of lifetime suicide attempt and rates of lifetime major depression in different ethnic groups in the United States. Acta Psychiatr. Scand. 110 (2004), 446–451.
154. Osborn, D, Levy, G, Nazareth, I, King, M, Suicide and severe mental illnesses. Cohort study within the UK general practice research database. Schizophr. Res. 99 (2008), 134–138.
155. Osby, U, Brandt, L, Correia, N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58 (2001), 844–850.
156. Owen, R, Gooding, P, Dempsey, R, Jones, S, A qualitative investigation into the relationship between social factors and suicidal thoughts and acts experienced by people with a bipolar disorder diagnosis. J. Affect. Disord. 176 (2015), 133–140.
157. Pandey, G, Dwivedi, Y, Ren, X, et al. Cyclic amp response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int. J. Neuropsychopharmacol. 10 (2007), 621–629.
158. Patorno, E, Bohn, R, Whal, P, et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent deaths. JAMA, 303, 2010, 1401.
159. Pawlak, J, Dmitrzak-Weglarz, M, Skibinska, M, et al. Suicide attempts and clinical risk factors in patients with bipolar and unipolar affective disorders. Gen. Hosp. Psychiatry 35 (2013), 427–432.
160. Perroud, N, Uher, R, Ng, M, Guipponi, M, Hauser, J, Henigsberg, N, et al. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics J. 12 (2012), 68–77.
161. Pivac, N, Pregelj, P, Nikolac, M, Zupanc, T, Nedic, G, Muck Seler, D, et al. The association between catechol-O-methyl-transferase Val108/158Met polymorphism and suicide. Genes Brain Behav. 10 (2011), 565–569.
162. Pompili, M, Gonda, X, Serafini, G, et al. Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord. 5 (2013), 457–490.
163. Pompili, M, Gonda, X, Serafini, G, et al. Epidemiology of suicide in bipolar disorders: a systematic review of literature. Bipolar Disord. 15 (2013), 457–490.
164. Pompili, M, Rihmer, Z, Innamorati, M, et al. Assessment and treatment of suicide risk in bipolar disorders. Exp. Rev. Neurother. 9 (2009), 109–136.
165. Pregelj, P, Nedic, G, Paska, A, Zupanc, T, Nikolac, M, Balazic, J, et al. The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. J. Affect. Disord. 128 (2011), 287–290.
166. Quiroz, J, Gray, N, Kato, T, Hanji, H, Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33 (2008), 2551–2565.
167. Ratta-Apha, W, Hishimoto, A, Yoshiba, M, Ueno, Y, Asano, M, Shirakawa, O, et al. Association study of BDNF with completed suicide in the Japanese population. Psychiatry Res. 209 (2013), 734–736.
168. Ray, K, Dutta, A, Panjwani, Y, Thakur, L, Anand, J, Kumar, S, Hypobaric hypoxia modulates brain biogenic amines and disturbs sleep architecture. Neurochem. Int. 58 (2011), 112–118.
169. Reutfors, J, Osby, U, Ekbom, A, Nordstrom, P, Jokinen, J, Papadopoulos, F, Seasonality of suicide in Sweden: relationship with psychiatric disorder. J. Affect. Disord. 119 (2009), 59–65.
170. Rezin, G, Amboni, G, Zugno, A, Quevedo, J, Steck, E, Mitochondrial dysfunction and psychiatric disorders. Neurochem. Res. 34 (2009), 1021–1029.
171. Rihmer, Z, Suicide risk in mood disorders. Curr. Opin. Psychiatry 20 (2007), 17–22.
172. Rihmer, Z, Akiskal, H, Do antidepressant t(h)reat(en) depressives? Towards clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J. Affect. Disord. 94 (2006), 3–13.
173. Rihmer, Z, Barsi, J, Arato, M, et al. Suicide in subtypes of primary major depression. J. Affect. Disord. 18 (1990), 221–225.
174. Rihmer, Z, Barsi, J, Arató M, Demeter, E, Suicide in subtypes of primary major depression. J. Affect. Disord. 18:3 (1990), 221–225.
175. Rihmer, Z, Szádóczky, E, Füredi, J, Kiss, K, Papp, Z, Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary. J. Affect. Disord. 67 (2001), 175–179.
176. Roy, A, Risk factors for suicide in psychiatric patients. Arch. Gen. Psychiatry 39 (1982), 1089–1095.
177. Roy, A, Segal, N, Suicidal behaviour in twins: a replication. J. Affect. Disord. 66 (2001), 71–74.
178. Roy, A, Segal, N, Centerwall, B, Robinette, C, Suicide in twins. Arch. Gen. Psychiatry 48 (1991), 29–32.
179. Rudd, M, Williams, B, Trotter, D, The psychological and behavioural treatment of suicidal behaviour: what are the common elements of treatment that work?. Wasserman, D., Wasserman, C., (eds.) Oxford Textbook of Suicidology and Suicide prevention: a Global Perspective, 2009, Oxford Uni., 427–447.
180. Saiz, P, Garcia - Portilla, P, Paredes, B, Corcoran, P, Arango, C, Morales, B, et al. Role of serotonergic-related systems in suicidal behavior: data from a case-control association study. Prog. Neuropsychoparmacol. Biol. Psychiatry 35 (2011), 1518–1524.
181. Samadi Rad, B, Ghasemi, A, Seifi, M, Samadikuchaksaraei, A, Baybordi, F, Danaei, N, Serotonin 1A receptor genetic variations, suicide, and life events in the Iranian population. Psychiatry Clin. Neurosci. 66 (2012), 337–343.
182. Sani, G, Tondo, L, Koukopoulos, A, et al. Suicide in a large population of former psychiatric inpatients. Psychiatry Clin. Neurosci. 65 (2011), 286–295.
183. Sarchiapone, M, Carli, V, Roy, A, et al. Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 57 (2008), 139–145.
184. Scaglia, F, The role of mitochondrial dysfunction in psychiatric disease. Dev. Disabil.Res. Rev. 16 (2010), 136–143.
185. Schaffer, A, Isometsa, E, Tondo, L, et al. International society for bipolar disorders task force on suicide: meta –analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disoder. 17 (2015), 1–16.
186. Schou, M., Suicidal behaviour and prophylactic lithium treatment of major mood disorders: a review of reviews. Suicide Life Threat. Behav. 30 (2000), 289–293.
187. Sears, C, Wilson, J, Fitches, A, Investigating the role of BDNF and CCK system genes in suicidality in a familial bipolar cohort. J. Affect. Disord. 151:2 (2013), 611–617.
188. Segal, J, Pujol, C, Birck, A, Gus Manfro, G, Leistner-Segal, S, Association between suicide attempts in south Brazilian depressed patients with the serotonin transporter polymorphism. Psychiatry Res. 143 (2006), 289–291.
189. Sequeira, A, Mamdanni, F, Lalovic, A, et al. Alpha 2A adrenergic receptor gene and suicide. Psychiatry Res. 125 (2004), 87–93.
190. Simon, G, Hunkeler, E, Fireman, B, Lee, J, Savarino, J, Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord. 9 (2007), 526–530.
191. Simon, G, Hunkeler, E, Fireman, B, Lee, J, Savarino, J, Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord.(9), 2007, 526–530.
192. Sondergard, L, Lopez, A, Andersen, P, Kessing, L, Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord. 10 (2008), 87–94.
193. Stanley, B, Brodsky, B, Dialectical behavioural therapy for suicidal individual. Suicidology and Suicide Prevention: A Global Perspective, 2009, 421–425.
194. Stanley, B, Brodsky, BS, Nelson JD, DR, Brief dialectal behaviour therapy (DBT-B) for suicidal behaviour and non-suicidal self injury. Arch. Suicide Res. 11 (2007), 337–341.
195. Stanley, B, Brown, G, Bret, D, et al. Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability. J. Am. Acad. Child Adolesc. Psychiatry 48 (2009), 1005–1013.
196. Stefulj, J, Kubat, M, Balija, M, Jernej, B, TPH gene polymorphism and aging: indication of combined effect on the predisposition to violent suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006), 139–141.
197. Stein, M, Ware, E, Mitchell, C, Chen, C, Borja, S, Cai, T, et al. Genomewide association studies of suicide attempts in US soldiers. Am. J. Med. Genet. B Neuropsychiatr. Genet.(8), 2017, 786–797.
198. Stenager, E, Wasserman, D, Somatic diseases and suicidal behaviour. Suicidology and Suicide Prevention: A Global Perspective, 2009, 293–299.
199. Stork, C, Renshaw, P, Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10 (2005), 900–919.
200. Swann, A, Lijffijt, M, Lane, S, Steinberg, J, Moeller, F, Increased trait-like impulsivity and course of illness in bipolar disorder. Bipolar Disord. 11 (2009), 280–288.
201. Takizawa, T, Suicide due to mental diseases based on the Vital Statistics Survey Death Form. Nihon Koshu Eisei Zasshi 59 (2012), 399–406.
202. Tidelman, D, Langstrom, N, Lichtenstein, P, Runeson, B, Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long – term follow-up. BMJ, 337, 2008, a2205.
203. Tohen, M, Tsuang, M, Goodwin, D, Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am. J. Psychiatry 149 (1992), 1580–1584.
204. Tondo, L, Baldessarini, R, Hennen, J, et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J. Clin. Psychiatry 60:2 (1999), 63–69.
205. Tondo, L, Isacsson, G, Baldessarini, R, Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 17 (2003), 491–511.
206. Tondo, L, Lepri, B, Baldessarini, R, Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr. Scand. 116 (2007), 419–428.
207. Tovilla-Zarate, C, Juarez-Rojo, I, Ramon-Frias, T, Villar-Soto, M, Pool-Garcia, S, Medellin, B, et al. No association between COMT val158met polymorphism and suicidal behavior; meta-analysis and new data. BMC Psychiatry, 11, 2011, 151.
208. Trouvin, J, Prioux-Guyonneau, M, Cohen, Y, Jacquot, C, Rat brain monoamine metabolism and hypobaric hypoxia: a new approach. Gen. Pharmacol. 17 (1986), 69–73.
209. Tsai, S, Chen, C, Hwu, W, et al. Comorbidity of substance abuse in patients with bipolar disorder: a 15-year follow-up study. Taiwan J. Psychiatry 10 (1996), 357–364.
210. Tsai, S, Chen, C, Yeh, E, Alcohol problems and long-term psychosocial outcome in Chinese patients with bipolar disorder. J. Affect. Disord. 46 (1997), 143–150.
211. Tsai, S, Lee, J, Chen, C, Characteristics and psychosocial problems of patients with bipolar disorder at high risk for suicide attempts. J. Affect. Disord. 52 (1999), 145–152.
212. Tsai, SY, Kuo, CJ, Chen, CC, Lee, HC, Risk factors for completed suicide in bipolar disorder. J. Clin. Psychiatry 63 (2002), 69–476.
213. Videtic, A, Zupanc, T, Pregelj, P, Balazic, J, Tomori, M, Komel, R, Suicide, stress and serotonin receptor 1A promoter polymorphism -1019C>G in Slovenian suicide victims. Eur. Arch. Psychiatry Clin. Neurosci. 259:4 (2009), 234–238.
214. Vieta, E, Benabarre, A, Colom, F, Gastó C, Nieto, E, Otero, A, et al. Suicidal behavior in bipolar I and bipolar II disorder. J. Nerv. Ment. Disord. 185:6 (1997), 407–409.
215. Vieta, E, Colom, F, Martínez-Aran, A, Benabarre, A, Gastó C, Personality disorders in bipolar II patients. J. Nerv. Ment. Dis. 187:4 (1999), 245–248.
216. Vieta, E, Salagre, E, Grande, I, Carvalho, A, Fernandes, B, Berk, M, et al. Early intervention in bipolar disorder. Am. J. Psychiatry 1:175 (2018), 411–426.
217. Vincze, I, Perroud, N, Buresi, C, Baud, P, Bellivier, F, Etain, B, et al. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord. 10 (2008), 580–587.
218. Walther, D, Peter, J, Bashammarkh, S, Hörtnagl, H, Voits, M, Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299, 2003, 76 (80-).
219. Wasserman, D, Suicidal people's experiences of negative life events. Suicide: An Unnecessary Death, 2001, 119–124.
220. Wasserman, D, Geijer, T, Sokolowski, M, Frisch, A, Michaelovsky, E, Weizman, A, et al. Association of the serotonin transporter promotor polymorphism with suicide attempters wiath a high medical damage. Eur. Neuropsychopharmacol. 17 (2007), 230–233.
221. Wasserman, D, Rihmer, Z, Rujescu, D, et al. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur. Psychiatry 27 (2012), 129–141.
222. Wasserman, D., Negative life events (losses, changes, traumas and narcissitic injury) and suicide. Suicide: An Unnecessary Death, 2001, 111–117.
223. Webb, R, Lichtenstein, P, Larsson, H, Geddes, J, Fazel, S, Suicide, hospital-presenting suicide attempts, and criminality in bipolar disorder: examination of risk for multiple adverse outcomes. J. Clin. Psychiatry 75:8 (2014), e809–e816.
224. Wood, A, Trainor, G, Rothwell, J, Moore, A, Harrington, R, Randomized trial of group therapy for repeated deliberate self-harm in adolescents. J. Am. Acad. Child Adolesc. Psychiatry 40 (2001), 1246–1253.
225. World Health Organitzation. WHO mortatility database [Internet]. Available from: http://www.who.int/news-room/fact-sheets/detail/suicide.
226. Yatham, L, Kennedy, S, Schaffer, A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 11 (2009), 225–255.
227. Yerevanian, B, Koek, R, Mintz, J, Bipolar pharmacotherapy and suicidal behaviour. Part I. Lithium, divalproex and carbamazepine. J. Affect. Disord. 103 (2007), 5–11.
228. Yerevanian, B, Koek, R, Mintz, J, Akiskal, H, Bipolar pharmacotherapy and suicidal behaviour. Part 2. The impact of antidepressants. J. Affect. Disord. 103 (2007), 13–21.
229. Zai, C, Manchia, M, De Luca, V, et al. The brain-derived neurotrophic factor gene in suicidal behaviour: a meta-analysis. Int. J. Neuropsychopharmacol. 15 (2012), 1037–1042.
230. Zarrilli, F, Angiolillo, A, Castaldo, G, Chiariotti, L, Keller, S, Sacchetti, S, et al. Brain derived neurotrophic factor (BDNF) genetic polymorphism (Val66Met) in suicide: a study of 512 cases. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (2009), 599–600.
231. Zill, P, Büttner, A, Eisenmenger, W, Möller, H, Bondy, B, Ackenheil, M, Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol. Psychiatry 56 (2004), 581–586.
232. Zouk, H, McGirr, A, Lebel, V, Benkelfat, C, Rouleau, G, Turecki, G, The effect of genetic variation of the serotonin 1B receptor gene on impulssive agressive behavior and suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B:8 (2007), 996–1002.